{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:55:35Z","timestamp":1790801735782,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest Radiol"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system and has been associated with reduced perfusion in normal-appearing white matter (NAWM). The magnitude of this hypoperfusion is unclear. The present study aims to quantify NAWM perfusion with dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) in patients with relapsing-remitting (RR) MS and in a control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>The statistical power of a DCE-MRI acquisition to reveal hypoperfusion in MS was estimated using a Monte Carlo simulation: synthetic tissue curves with a contrast-to-noise ratio of 8 were generated for MS patients and control group using perfusion values reported in previous studies. A compartment-uptake model was fitted to these curves, yielding estimates of cerebral blood flow (CBF), cerebral blood volume (CBV), and permeability-surface area product (PS). This was repeated 1000 times. Mean and standard deviation of the resulting distributions were used to calculate the statistical power of a DCE-MRI study to detect perfusion differences between 16 control subjects and 24 MS subjects.<\/jats:p>\n            <jats:p>In an institutional review board\u2013approved study, patients with RR-MS (n = 24; mean age, 36 years; 17 women, mean Enhanced Disability Status Scale score, 3.25) and patients without history or symptoms of neurological disorder (n = 16; mean age, 49 years; 9 women) underwent a DCE-MRI examination with a previously established MRI protocol (3D SPGR sequence; 2.1 seconds temporal resolution; 44 slices; spatial resolution, 1.7 \u00d7 1.7 \u00d7 3 mm). Regions were defined manually in the middle cerebral artery; in the frontal, periventricular, and occipital NAWM; in the pons; and in the thalamus, and CBF, CBV, and PS were quantified using a compartment-uptake model.<\/jats:p>\n            <jats:p>Parameter differences between MS and control groups were evaluated using a mixed linear model with subjects as random effect and controlling for age and sex. A <jats:italic toggle=\"yes\">P<\/jats:italic> value of less than 0.05 was considered to indicate statistical significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>For all but one of previously reported effect sizes, the simulation study estimated a statistical power of 80% to 100% to detect reduced CBF in MS. In the patient study, mean (standard deviation) CBF in NAWM was 11.0 (15.1) and 10.4 (8.2) mL\/100 mL per minute in the MS and control groups, respectively. Mean CBV in NAWM was 0.50 (0.45) mL\/100 mL in the MS group and 0.48 (0.28) mL\/100 mL in the control group. Mean values of PS in NAWM were 0.002 mL (0.027)\/100 mL per minute in the control group and \u22120.001 (0.015) mL\/100 mL per minute in the MS patients. Differences between patient groups were not statistically significant for CBF, CBV, mean transit time, and PS (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.44, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.20, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.78, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.66, respectively). In both groups, the influence of age on any parameter was nonsignificant. Cerebral blood flow and CBV in the thalamus and pons were significantly higher than in NAWM regions (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 1e-4); mean transit time was significantly shorter than in NAWM (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 1e-4). Permeability-surface area product was not significantly different from zero (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.25) in all evaluated regions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite high statistical power, we could not confirm previous reports of NAWM hypoperfusion in MS. This indicates that, at least in our patient cohort, potential hypoperfusion is much less pronounced than reported in previous studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rli.0000000000000320","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T20:34:51Z","timestamp":1471638891000},"page":"135-141","source":"Crossref","is-referenced-by-count":21,"title":["Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis"],"prefix":"10.1097","volume":"52","author":[{"given":"Michael","family":"Ingrisch","sequence":"first","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sourbron","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Herberich","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz J\u00f6rg","family":"Schneider","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Hohlfeld","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian F.","family":"Reiser","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Ertl-Wagner","sequence":"additional","affiliation":[{"name":"From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; \u2020Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; \u2021Institute for Clinical Radiology, and \u00a7Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and \u2225Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.47.11.1182","article-title":"Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis","volume":"47","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03164835","article-title":"Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study","volume":"12","year":"1998","journal-title":"Ann Nucl Med"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000116926","article-title":"Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime","volume":"33","year":"1993","journal-title":"Eur Neurol"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiol.2313030996","article-title":"Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter","volume":"231","year":"2004","journal-title":"Radiology"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuroimage.2006.08.008","article-title":"Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T","volume":"33","year":"2006","journal-title":"Neuroimage"},{"key":"bib6-20231021","first-page":"1539","article-title":"Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity","volume":"26","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.jcbfm.9600504","article-title":"Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis","volume":"28","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib8-20231021","first-page":"767","article-title":"Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis","volume":"28","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib9-20231021","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1073\/pnas.1222560110","article-title":"Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/jcbfm.2015.131","article-title":"Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?","volume":"35","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib11-20231021","doi-asserted-by":"crossref","first-page":"e0119356","DOI":"10.1371\/journal.pone.0119356","article-title":"Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"bib12-20231021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLI.0b013e31823bfc97","article-title":"Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3 T","volume":"47","year":"2012","journal-title":"Invest Radiol"},{"key":"bib13-20231021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10928-013-9315-3","article-title":"Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer","volume":"40","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"bib15-20231021","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/mrm.21901","article-title":"Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography","volume":"61","year":"2009","journal-title":"Magn Reson Med"},{"issue":"suppl 1","key":"bib16-20231021","first-page":"539","article-title":"PMI: platform for research in medical imaging","volume":"22","year":"2009","journal-title":"Magn Reson Mater Phy"},{"key":"bib17-20231021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/mrm.22005","article-title":"Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI","volume":"62","year":"2009","journal-title":"Magn Reson Med"},{"key":"bib19-20231021","first-page":"7","article-title":"Diagnostic checking in regression relationships","volume":"2","year":"2002","journal-title":"R News"},{"key":"bib21-20231021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"bib22-20231021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mrm.1188","article-title":"Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart","volume":"46","year":"2001","journal-title":"Magn Reson Med"},{"key":"bib23-20231021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jmri.23837","article-title":"Impact of transvascular and cellular-interstitial water exchange on dynamic contrast-enhanced magnetic resonance imaging estimates of blood to tissue transfer constant and blood plasma volume","volume":"37","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"bib24-20231021","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/mrm.21748","article-title":"Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle","volume":"60","year":"2008","journal-title":"Magn Reson Med"},{"key":"bib25-20231021","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/mrm.22430","article-title":"Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: a preliminary comparison to assess the magnitude of water exchange effects","volume":"64","year":"2010","journal-title":"Magn Reson Med"},{"key":"bib26-20231021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10334-009-0190-2","article-title":"Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities","volume":"23","year":"2010","journal-title":"MAGMA"},{"key":"bib27-20231021","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLI.0000000000000154","article-title":"Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy","volume":"50","year":"2015","journal-title":"Invest Radiol"},{"key":"bib28-20231021","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","year":"2014","journal-title":"Invest Radiol"},{"key":"bib29-20231021","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","year":"2015","journal-title":"Radiology"},{"key":"bib30-20231021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia","volume":"73","year":"2015","journal-title":"Magn Reson Med"},{"key":"bib31-20231021","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1088\/0031-9155\/57\/2\/R1","article-title":"Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability","volume":"57","year":"2012","journal-title":"Phys Med Biol"},{"key":"bib32-20231021","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/nbm.2940","article-title":"Classic models for dynamic contrast-enhanced MRI","volume":"26","year":"2013","journal-title":"NMR Biomed"},{"key":"bib33-20231021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nicl.2013.12.001","article-title":"Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI","volume":"4","year":"2014","journal-title":"NeuroImage Clin"},{"key":"bib34-20231021","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/jcbfm.2014.126","article-title":"Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients","volume":"34","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib35-20231021","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroimage.2015.10.018","article-title":"Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability","volume":"125","year":"2016","journal-title":"Neuroimage"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004424-201703000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T05:17:02Z","timestamp":1697865422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004424-201703000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rli.0000000000000320","relation":{},"ISSN":["1536-0210","0020-9996"],"issn-type":[{"value":"1536-0210","type":"electronic"},{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}